Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms driving the immunoregulatory function of cancer cells
Antoinette van Weverwijk, Karin E. de Visser
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 193-215
Closed Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A. Quezada
Immunity (2023) Vol. 56, Iss. 10, pp. 2270-2295
Open Access | Times Cited: 47
Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine
Shogo Kumagai, Kota Itahashi, Hiroyoshi Nishikawa
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 337-353
Closed Access | Times Cited: 38
Lanthanide-based nanoparticles for cancer phototherapy
Zichao Luo, Duo Mao, Xinchao Li, et al.
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215773-215773
Open Access | Times Cited: 20
Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy
Junhua Li, Quan Zhao, Nan Zhang, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 13226-13240
Closed Access | Times Cited: 15
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Clinical advances of mRNA vaccines for cancer immunotherapy
Alexey V. Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.
Med (2025) Vol. 6, Iss. 1, pp. 100562-100562
Closed Access | Times Cited: 4
Escape from T-cell–targeting immunotherapies in acute myeloid leukemia
Jayakumar Vadakekolathu, Sergio Rutella
Blood (2023) Vol. 143, Iss. 26, pp. 2689-2700
Open Access | Times Cited: 29
Cancer drug-tolerant persister cells: from biological questions to clinical opportunities
Mariangela Russo, Mengnuo Chen, Elisa Mariella, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 10, pp. 694-717
Closed Access | Times Cited: 11
Serine Depletion Promotes Anti-Tumor Immunity by Activating Mitochondrial DNA-mediated cGAS-STING Signaling
Suchandrima Saha, Monisankar Ghosh, Jinyu Li, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2645-2659
Closed Access | Times Cited: 10
Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation
Zhigang Nian, Yingchao Dou, Yiqing Shen, et al.
Immunity (2024) Vol. 57, Iss. 10, pp. 2344-2361.e7
Open Access | Times Cited: 10
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Neutrophil‐Targeting Semiconducting Polymer Nanotheranostics for NIR‐II Fluorescence Imaging‐Guided Photothermal‐NO‐Immunotherapy of Orthotopic Glioblastoma
Jiansheng Liu, Danling Cheng, Anni Zhu, et al.
Advanced Science (2024) Vol. 11, Iss. 39
Open Access | Times Cited: 8
Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells
Zi-Jian Cao, Jia You, Yu-Meng Fan, et al.
Science Advances (2025) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Erythroid progenitor cell–mediated spleen–tumor interaction deteriorates cancer immunity
Zhi‐Zhong Wu, Wei‐Wei Deng, Su‐Wen Zhu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 9
Open Access | Times Cited: 1
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
Zerui Zhang, Wenjie Huang, Dian Hu, et al.
Gut (2025), pp. gutjnl-333944
Closed Access | Times Cited: 1
Bacterial outer membrane vesicles in cancer: Biogenesis, pathogenesis, and clinical application
Deming Li, Lisi Zhu, Yuxiao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115120-115120
Open Access | Times Cited: 17
Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies
Mingqing Huang, Zhuocen Cha, Rui Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
Yuqing Pan, Xiangdong Xue, Xing‐Jie Liang
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 6
Bioorthogonal Quinone Methide Decaging Enables Live-Cell Quantification of Tumor-Specific Immune Interactions
Yan Zhang, Shibo Liu, Fuhu Guo, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 15186-15197
Closed Access | Times Cited: 6
Combination of MHI148 Targeted Photodynamic Therapy and STING Activation Inhibits Tumor Metastasis and Recurrence
Huilin Yu, Qiaoqi Chen, Min Zheng, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 23, pp. 29672-29685
Closed Access | Times Cited: 6
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Decoding immunogenic cell death from a dendritic cell perspective
Sophie Janssens, Sofie Rennen, Patrizia Agostinis
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 350-370
Open Access | Times Cited: 15
Paeonol repurposing for cancer therapy: From mechanism to clinical translation
Ying Wang, BING-SHU LI, Zihui Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115277-115277
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top